[Histologic and hormone-analytical studies in acyclic continuous therapy with ovulation-inhibitors].
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000740:Anemia / Q000209:etiology*; D001706:Biopsy; D004715:Endometriosis / Q000188:drug therapy*; D004967:Estrogens; D005260:Female; D006062:Gonadotropins; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D007889:Leiomyoma; D008234:Lynestrenol / Q000627:therapeutic use*; D008599:Menstruation Disturbances / Q000150:complications*; D011276:Pregnanediol; D014556:Urine; D014599:Uterus / Q000473:pathology*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D006062:Gonadotropins; D011276:Pregnanediol; D008234:Lynestrenol
Histologische und hormonanalytische Untersuchungen bei azyklischer Dauertherapie mit Ovulationshemmern.